Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pfeffer

Showing results (461-470 of 908) with videos related to

Pageof 91
Sort By:
European Journal of Heart Failure|February 19, 2019
Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trialBrian A Bergmark, Jacob A Udell, David A Morrow, et al.
Circulation. Heart Failure|May 31, 2014
Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fractionNatalie A Bello, Brian Claggett, Akshay S Desai, et al.
European Journal of Heart Failure|October 31, 2009
Adherence to medication according to sex and age in the CHARM programmeBradi B Granger, Inger Ekman, Christopher B Granger, et al.
Stroke|January 29, 2015
Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failureRoopinder K Sandhu, Stefan H Hohnloser, Marc A Pfeffer, et al.
The American Journal of Cardiology|July 7, 2009
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial)Robert M Califf, Yuliya Lokhnygina, Eric J Velazquez, et al.
The American Journal of Cardiology|September 28, 1995
Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE InvestigatorsM A Pfeffer, F M Sacks, L A Moyé, et al.
European Journal of Heart Failure|March 22, 2017
Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fractionTor Biering-Sørensen, Sanjiv J Shah, Inder Anand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 18, 2012
Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responsesAlexandre P Rogerio, Oliver Haworth, Roxanne Croze, et al.
American Heart Journal|March 29, 2008
Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndromeLisa M Mielniczuk, Marc A Pfeffer, Eldrin F Lewis, et al.
European Journal of Heart Failure|December 2, 2017
Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failureEmil Wolsk, Brian Claggett, Lars Køber, et al.
Pageof 91

Showing results (461-470 of 908) with videos related to

Sort By:
Pageof 91
European Journal of Heart Failure|February 19, 2019
Klotho, fibroblast growth factor-23, and the renin-angiotensin system - an analysis from the PEACE trialBrian A Bergmark, Jacob A Udell, David A Morrow, et al.
Circulation. Heart Failure|May 31, 2014
Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fractionNatalie A Bello, Brian Claggett, Akshay S Desai, et al.
European Journal of Heart Failure|October 31, 2009
Adherence to medication according to sex and age in the CHARM programmeBradi B Granger, Inger Ekman, Christopher B Granger, et al.
Stroke|January 29, 2015
Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failureRoopinder K Sandhu, Stefan H Hohnloser, Marc A Pfeffer, et al.
The American Journal of Cardiology|July 7, 2009
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial)Robert M Califf, Yuliya Lokhnygina, Eric J Velazquez, et al.
The American Journal of Cardiology|September 28, 1995
Cholesterol and Recurrent Events: a secondary prevention trial for normolipidemic patients. CARE InvestigatorsM A Pfeffer, F M Sacks, L A Moyé, et al.
European Journal of Heart Failure|March 22, 2017
Prognostic importance of left ventricular mechanical dyssynchrony in heart failure with preserved ejection fractionTor Biering-Sørensen, Sanjiv J Shah, Inder Anand, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 18, 2012
Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responsesAlexandre P Rogerio, Oliver Haworth, Roxanne Croze, et al.
American Heart Journal|March 29, 2008
Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndromeLisa M Mielniczuk, Marc A Pfeffer, Eldrin F Lewis, et al.
European Journal of Heart Failure|December 2, 2017
Contribution of cardiac and extra-cardiac disease burden to risk of cardiovascular outcomes varies by ejection fraction in heart failureEmil Wolsk, Brian Claggett, Lars Køber, et al.
Pageof 91